Abstract
Ayurveda states two treatment modalities i.e. Dravyabhuta (pharmacological therapy) and Adravyabhuta (non-pharmacological therapy). Santarpana can be explained as the nourishment of Dhatus and Indriyas up to its saturating level. Improper or excessive exposure to Santarpana can lead to various disorders, known as Santarpanajanya Vikaras. Hypertriglyceridemia, defined as fasting serum triglyceride levels of 150 mg/dL or higher, is associated with increased risk of cardiovascular disease can enlist under Santarpanjanya Vikara. The prevalence of hypertriglyceridemia is 32.1%, with more than 10 million cases per year in India. Material & Methods- Review was done from various Ayurvedic classical texts, modern textbooks, published research papers, different databases such as PubMed, Google scholar etc. and subject related data on internet. Discussion- Santarpana Janya Hetus like Ati Madhura, Ati Snigdha Ahara, Avyayama, Atyashana etc. lead to vitiation of Jatharagni and production of Ama. This Jatharagni Dushti and Aama cause Medo Dhatwagnimandya which further leads to formation of Aama Asthayi Medas (hyperlipidaemia) alone or together with Sthayi Meda Dhatu (obesity). The non-pharmacological management includes reassurance, lifestyle modifications including observance of Dinacharya, Ritucharya, dietary interventions like intake of Pathyaahara, healthy low-calorie, low-fat diet, and moderate physical activity, implementing Sadvritta- the ideal code of conduct, performing yoga etc. Conclusion- Ayurvedic treatment offers a holistic approach that treats the body, mind, and soul instead of treating the symptoms or disease only. Hence, Chikitsa has been classified into three categories: Daivavyapashraya, Yuktivyapashraya, and Satvavajaya Chikita. Thus, Ayurveda plays a significant role in the non-pharmacological management of Hypertriglyceridemia